22q13 deletion / Phelan-McDermid Syndrome and depression

TL;DR: Phelan-McDermid syndrome (22q13 deletion) is often associated with neurodevelopmental challenges, and while formal data on depression prevalence is limited, many individuals experience anxiety, social withdrawal, and mood dysregulation due to communication barriers and sensory processing differences. Mental health support for those with Phelan-McDermid syndrome should be highly individualized, focusing on non-verbal communication, behavioral stabilization, and environmental adjustments to alleviate psychological distress.

How does Phelan-McDermid syndrome affect emotional and mental health?

Individuals with Phelan-McDermid syndrome often face unique emotional challenges stemming from the deletion of the SHANK3 gene, which is critical for synaptic function. Because many people with Phelan-McDermid syndrome have limited expressive language, their emotional distress often manifests as behavioral changes, increased self-injury, or sleep disturbances rather than verbal reports of "feeling sad." Research suggests that the neurological basis of Phelan-McDermid syndrome, specifically the disruption of synaptic pathways, may influence how patients process emotions and manage anxiety, potentially increasing vulnerability to mood disorders.

What are the common signs of depression in individuals with this condition?

Identifying depression in patients with Phelan-McDermid syndrome requires observing shifts from a person’s "baseline" behavior. Because communication may be non-verbal or limited, caregivers should look for specific indicators of psychological distress:

• Social Withdrawal: A marked loss of interest in activities or people that previously brought joy.


• Sleep Disturbances: Significant changes in sleep patterns, such as increased insomnia or excessive daytime sleeping.


• Behavioral Regression: An increase in repetitive behaviors, self-injurious actions, or uncharacteristic aggression.


• Physical Complaints: Increased sensitivity to sensory input or unexplained physical discomfort that may be a proxy for emotional pain.


• Appetite Changes: Notable shifts in eating habits or food aversions.

How are anxiety and depression managed in Phelan-McDermid syndrome?

Treatment for Phelan-McDermid syndrome must be multidisciplinary. While traditional talk therapy like CBT may not be accessible for those with severe cognitive or communication impairments, adapted interventions—such as Applied Behavior Analysis (ABA) focused on emotional regulation or sensory integration therapy—can be highly effective. Medication may be used to address severe anxiety or mood instability, but it must be managed by a psychiatrist familiar with the genetic profile of Phelan-McDermid syndrome, as patients may have unique sensitivities to pharmacological agents.

What is the impact of chronic fatigue and disability on mental wellbeing?

The burden of managing Phelan-McDermid syndrome, including chronic health issues like epilepsy, gastrointestinal distress, and sleep disorders, contributes significantly to the mental health of both the patient and their caregivers. Chronic fatigue and pain can exacerbate mood instability. At DiseaseMaps.org, 35 community members have shared their experiences, highlighting that peer support is vital in navigating these complex, intersecting challenges. Addressing the physical comfort of the patient is often the first, most effective step in improving their overall psychological state.

Next steps

• Consult a specialist: Seek a psychiatrist or neurologist experienced in neurodevelopmental disorders to evaluate mood-related behavioral changes.


• Connect with the community: Engage with the 35 members on DiseaseMaps.org to share coping strategies and local resource recommendations.


• Document behaviors: Keep a daily log of mood, sleep, and behavioral changes to provide your medical team with objective data.


• Crisis Support: If you or a loved one are in immediate distress or experiencing suicidal thoughts, contact the 988 Suicide & Crisis Lifeline in the US by calling or texting 988, or contact your local emergency services immediately.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health needs.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Phelan-McDermid Syndrome Overview.


• Orphanet: 22q13.3 deletion syndrome (Phelan-McDermid syndrome) entry.


• Phelan-McDermid Syndrome Foundation (pmsf.org): Clinical resources and family support guides.


• OMIM (Online Mendelian Inheritance in Man): SHANK3 gene and associated phenotypic data.